NCT02768597

Brief Summary

The study will compare the outcome of primary reverse shoulder arthroplasty using the Stryker ReUnion System with implantation of either a large (40 mm) or a small (36 mm) glenosphere with either a +2 mm or a +6 mm offset.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

April 20, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 11, 2016

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 13, 2024

Completed
Last Updated

February 13, 2024

Status Verified

January 1, 2024

Enrollment Period

6.7 years

First QC Date

April 20, 2016

Results QC Date

December 12, 2023

Last Update Submit

January 18, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Active Forward Elevation of the Shoulder

    Degrees of movement the participant is able to independently lift arm upward to the ceiling, while keeping elbow straight. Normal movement for forward elevation is 180 degrees.

    One year

  • Active External Rotation of the Shoulder

    Degrees of movement the participant is able to independently rotate arm up, while keeping arm at 0 degrees of abduction. Normal movement for external rotation is 90 degrees.

    One year

  • Shoulder Abduction Strength

    Shoulder abduction strength was measured using manual testing where strength was graded as: (1) paralysis; (2) contraction with no ability to resist gravity; (3) weak but able to resist gravity; (4) weak but able to resist the examiner; (5) normal.

    one year

  • Shoulder External Rotation Strength

    Shoulder external rotation strength was measured using manual testing where strength was graded as: (1) paralysis; (2) contraction with no ability to resist gravity; (3) weak but able to resist gravity; (4) weak but able to resist the examiner; (5) normal.

    One year

  • Shoulder Internal Rotation Strength

    Shoulder internal rotation strength was measured using manual testing where strength was graded as: (1) paralysis; (2) contraction with no ability to resist gravity; (3) weak but able to resist gravity; (4) weak but able to resist the examiner; (5) normal.

    One year

Secondary Outcomes (5)

  • Oxford Shoulder Score (OSS) Questionnaire

    1 year

  • American Shoulder and Elbow Surgeons (ASES) Questionnaire

    One year

  • Quick DASH (Disabilities of the Arm Shoulder and Hand) Questionnaire

    One year

  • Shoulder Pain

    One year

  • Patient Satisfaction

    One year

Study Arms (4)

Large-Diameter Glenosphere +2 mm offset

ACTIVE COMPARATOR

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +2 mm offset

Device: ReUnion System with a Large-Diameter Glenosphere +2 mm offset

Small-Diameter Glenosphere +2 mm offset

ACTIVE COMPARATOR

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +2 mm offset

Device: ReUnion System with a Small-Diameter Glenosphere +2 mm offset

Large-Diameter Glenosphere +6 mm offset

ACTIVE COMPARATOR

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +6 mm offset

Device: ReUnion System with a Large-Diameter Glenosphere +6 mm offset

Small-Diameter Glenosphere +6 mm offset

ACTIVE COMPARATOR

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +6 mm offset

Device: ReUnion System with a Small-Diameter Glenosphere +6 mm offset

Interventions

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +2 mm offset

Large-Diameter Glenosphere +2 mm offset

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +2 mm offset

Small-Diameter Glenosphere +2 mm offset

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Large-Diameter Glenosphere +6 mm offset

Large-Diameter Glenosphere +6 mm offset

Primary Reverse Shoulder Arthroplasty using the ReUnion System with a Small-Diameter Glenosphere +6 mm offset

Small-Diameter Glenosphere +6 mm offset

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects willing to sign the informed consent
  • Male and non-pregnant female subjects ages 50 - 90 at the time of surgery
  • Subjects requiring a primary reverse total shoulder arthroplasty
  • Subjects with the diagnosis of cuff-tear arthropathy (CTA), massive irreparable rotator cuff tear (MRCT) or osteoarthritis (OA) with marked posterior subluxation or bone loss

You may not qualify if:

  • Inability to comply with follow-up requirements
  • Subjects with inflammatory arthritis
  • Subjects with proximal humerus fractures
  • Subjects with sequels of trauma
  • Subjects that are immunologically compromised
  • Subjects with an active or suspected latent infection in or about the shoulder
  • Need to add a tendon transfer
  • Need for structural humeral bone graft
  • Pregnant subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

Results Point of Contact

Title
Dr. Mark E. Morrey
Organization
Mayo Clinic

Study Officials

  • Mark Morrey, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 20, 2016

First Posted

May 11, 2016

Study Start

April 1, 2016

Primary Completion

December 15, 2022

Study Completion

December 15, 2022

Last Updated

February 13, 2024

Results First Posted

February 13, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations